Fig. 1 Sequential immunological events leading to HBsAg seroclearance following allo-HSCT.
This schematic delineates the transition from chronic HBV-induced immune tolerance to adoptive immune-mediated viral clearance through two critical phases. (A) Barriers before HSCT: immunosuppressive milieu in chronic HBV infection. Prior to transplantation, the hepatic microenvironment is characterized by profound immune dysfunction. Infected hepatocytes contribute to antigen overload and harbor persistent viral reservoirs. HBV-specific CD8⁺ T cells exhibit functional exhaustion, as evidenced by upregulated inhibitory receptors including PD-1, TIM-3, and CTLA-4. This exhausted state is reinforced by immunosuppressive cellular components, including regulatory T cells (Tregs), myeloid-derived suppressor cells (MDSCs), and Kupffer cells secreting TGF-β and IL-10. Concurrently, effector cytokine production (IFN-γ and TNF-α) is markedly diminished. Atypical B cells exhibit impaired antibody generation (anti-HBs↓), collectively precluding effective viral clearance. (B) Adoptive immune mechanisms after HSCT: Myeloablative conditioning reduces host suppressive cells, enabling donor engraftment. Donor CD8+ T cells are activated by Batf3⁺XCR1+ cDC1s via cross-presentation, with CD4+ T-cell help (CD40L-CD40, TCR-MHCII). They clear infected hepatocytes through cytolytic (perforin/granzyme) and non-cytolytic (IFN‑γ, IL‑2, TNF) pathways. Donor B cells produce anti‑HBs, neutralizing virus and mediating ADCC/ADCP via Fc receptors; some B cells become long‑lived plasma cells in bone marrow, ensuring sustained immunity. Created with BioGDP.com.102 ADCC, antibody-dependent cellular cytotoxicity; ADCP, antibody-dependent cellular phagocytosis; ALT, alanine aminotransferase; anti-HBs, antibodies to hepatitis B surface antigen; Batf3, basic leucine zipper ATF-like transcription factor 3; cccDNA, covalently closed circular DNA; CD40L, CD40 ligand; cDC1, type 1 conventional dendritic cell; CTLA-4, cytotoxic T-lymphocyte-associated protein 4; HBV, hepatitis B virus; HBsAg, hepatitis B surface antigen; HSCT, hematopoietic stem cell transplantation; IFN-γ, interferon gamma; IL, interleukin; MDSC, myeloid-derived suppressor cell; MHCII, major histocompatibility complex class II; NK, natural killer; PD-1, programmed cell death protein 1; TCR, T-cell receptor; TGF-β, transforming growth factor beta; TIM-3, T-cell immunoglobulin and mucin-domain-containing protein 3; TNF, tumor necrosis factor; Treg, regulatory T cell; XCR1, chemokine (C motif) receptor 1.